Covid-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis.

ABSTRACT:

Background

The novel coronavirus (COVID-19), caused by SARS-CoV-2, showed various prevalence and case-fatality rates (CFR) among patients with different pre-existing chronic conditions. End-stage renal disease (ESRD) patients with renal replacement therapy (RRT) might have a higher prevalence and CFR due to reduced immune function from uremia and kidney tropism of SARS-CoV-2, but there was a lack of systematic study on the infection and mortality of the SARS-CoV-2 infection in ESRD patients with various RRT.

Methodology/principal findings

We searched five electronic databases and performed a systematic review and meta-analysis up to June 30, 2020, to evaluate the prevalence and case fatality rate (CFR) of the COVID-19 infection among ESRD patients with RRT. The global COVID-

SUBMITTER: Nopsopon T 

PROVIDER: S-EPMC8232454 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature